Behind the row about migrants lies a collapse of trust
Exploiting them could harm the environment
Paris and Rome, once at loggerheads, now agree on migration, defence and more
For now, all the top players are male
What to expect from the new three-party government
Compulsory vaccination may become more common
Paris and Rome, once at loggerheads, now agree on migration, defence and more
Compulsory vaccination against covid-19 may become more common in Europe
What will happen to the nuclear bombs deployed there?
Mikheil Saakashvili has been on hunger strike for six weeks
The emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and Russia’s Gamaleya Institute said on Monday that they had initiated work on developing new versions of their respective vaccines adapted to the mutant strain. Pfizer and Moderna too said they were racing to tweak their vaccines.
Expressing support for Africa, which has been rattled by the discovery of Covid-19 variant Omicron, the government on Monday announced it had cleared all orders placed so far by the UN-backed Covax programme for supplies of Covishield vaccines, including to African countries like Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho. The government expressed solidarity in a statement with countries, particularly in Africa, that have so far been affected by Omicron.